Citation: K. Rehse et F. Brehme, New NO donors with antithrombotic and vasodilating activities, part 27: Azide oximes and 1-hydroxytetrazoles, ARCH PHARM, 333(6), 2000, pp. 157-161
Citation: R. Camehn et K. Rehse, New NO donors with antithrombotic and vasodilating activities, Part 28 N-(1-cyanoalkyl)-N-hydroxyureas, ARCH PHARM, 333(1), 2000, pp. 27-31
Authors:
Guhring, H
Gorig, M
Ates, M
Coste, O
Zeilhofer, HU
Pahl, A
Rehse, K
Brune, K
Citation: H. Guhring et al., Suppressed injury-induced rise in spinal prostaglandin E-2 production and reduced early thermal hyperalgesia in iNOS-deficient mice, J NEUROSC, 20(17), 2000, pp. 6714-6720
Citation: M. Herpel et K. Rehse, New NO donors with antithrombotic and vasodilating activities, part 22 - Nitrosation products of hexamethylenetetramine, ARCH PHARM, 332(7), 1999, pp. 255-257
Citation: K. Rehse et al., Interaction of viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities (vol 332, 182, 1999), ARCH PHARM, 332(6), 1999, pp. 222-222
Citation: K. Rehse et al., Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities, ARCH PHARM, 332(5), 1999, pp. 182-184
Citation: K. Rehse et F. Brehme, New NO donors with antithrombotic and vasodilating activities, part 26 amidoximes and their prodrugs, ARCH PHARM, 331(12), 1998, pp. 375-379
Citation: K. Rehse et T. Shahrouri, New NO donors with antithrombotic and vasodilating activities, part 25 hydroxylamine derivatives, ARCH PHARM, 331(11), 1998, pp. 365-367
Citation: K. Rehse et al., 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties, PHARMAZIE, 53(12), 1998, pp. 820-824